Rare Disease Focus: The Growing Investment in Methylmalonic Acidemia Research
The global Methylmalonic Acidemia (MMA) market is projected to witness significant growth in the coming years. Valued at USD 9.16 billion in 2022, the market is expected to grow at a compound annual growth rate (CAGR) of 5.0% during the forecast period. This growth trajectory is attributed to increasing awareness about rare metabolic disorders, technological advancements in genetic...
0 Comments 0 Shares